Fernando Magro

Prof. Fernando Magro

Department of Biomedicine, Unit of Pharmacology and Therapeutics, University of Porto, Porto, Portugal.
+2
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2017 in Journal of Crohn's and Colitis
Verified
Journal Article
Open access
PDF file
Fernando MagroFernando Magro
Fernando Magro
PGPaolo Gionchetti
Paolo Gionchetti
RERami Eliakim
Rami Eliakim
SASandro Ardizzone
Sandro Ardizzone
AAAlessandro Armuzzi
Alessandro Armuzzi
F[For The European Crohn’s And Colitis Organisation [Ecco]
For The European Crohn’s And Colitis Organisation [Ecco]
This is the third European Crohn’s and Colitis Organisation [ECCO] consensus guideline that addresses ulcerative colitis [UC]. It has been drafted by 28 ECCO members from 14 European countries. It is derived from and updates the previous ECCO consensus advice on UC.1–3 All the authors recognise and are grateful to previous ECCO members who contributed to creating the previous consensus guidelines1–6 on which some of the text is based. Attention is also drawn to other ECCO consensus guidelines which have contributed to this endeavour, on extra-intestinal manifestations [EIMs],7 malignancy,8 imaging,9 small bowel endoscopy,10 opportunistic infections [OIs],11 surgery,12 endoscopy,13 pathology,14 anaemia,15 reproduction and pregnancy,16 and paediatric UC.17

11 November 2019 in Journal of Crohn's and Colitis
Verified
Journal Article
Closed access
JTJoana Torres
Joana Torres
Stefanos BonovasStefanos Bonovas
Stefanos Bonovas
GDGlen Doherty
Glen Doherty
TKTorsten Kucharzik
Torsten Kucharzik
JGJavier P Gisbert
Javier P Gisbert
GFGionata Fiorino
Gionata Fiorino

1 June 2014 in Journal of Crohn's and Colitis
Verified
Journal Article
Open access
JRJ.F. Rahier
J.F. Rahier
Fernando MagroFernando Magro
Fernando Magro
CACandida Manuela Ferreira Abreu
Candida Manuela Ferreira Abreu
AAA. Armuzzi
A. Armuzzi
SBS. Ben-Horin
S. Ben-Horin
JCJ.F. Colombel
J.F. Colombel
SCOPUS: ar.jinfo:eu-repo/semantics/publishe

1 December 2012 in Journal of Crohn's and Colitis
Verified
Journal Article
Closed access
ADAxel Dignass
Axel Dignass
RERami Eliakim
Rami Eliakim
Fernando MagroFernando Magro
Fernando Magro
CMChristian Maaser
Christian Maaser
YCYehuda Chowers
Yehuda Chowers
GAGert Van Assche
Gert Van Assche

1 November 2013 in Journal of Crohn's and Colitis
Verified
Journal Article
Closed access
Fernando MagroFernando Magro
Fernando Magro
CLC. Langner
C. Langner
ADA. Driessen
A. Driessen
AEA. Ensari
A. Ensari
KGK. Geboes
K. Geboes
RER. Eliakim
R. Eliakim
The histologic examination of endoscopic biopsies or resection specimens remains a key step in the work-up of affected inflammatory bowel disease (IBD) patients and can be used for diagnosis and differential diagnosis, particularly in the differentiation of UC from CD and other non-IBD related colitides. The introduction of new treatment strategies in inflammatory bowel disease (IBD) interfering with the patients' immune system may result in mucosal healing, making the pathologists aware of the impact of treatment upon diagnostic features. The European Crohn's and Colitis Organisation (ECCO) and the European Society of Pathology (ESP) jointly elaborated a consensus to establish standards for histopathology diagnosis in IBD. The consensus endeavors to address: (i) procedures required for a proper diagnosis, (ii) features which can be used for the analysis of endoscopic biopsies, (iii) features which can be used for the analysis of surgical samples, (iv) criteria for diagnosis and differential diagnosis, and (v) special situations including those inherent to therapy. Questions that were addressed include: how many features should be present for a firm diagnosis? What is the role of histology in patient management, including search for dysplasia? Which features if any, can be used for assessment of disease activity? The statements and general recommendations of this consensus are based on the highest level of evidence available, but significant gaps remain in certain areas.

1 August 2013 in Journal of Crohn's and Colitis
Verified
Journal Article
Closed access
JPJ. Panes
J. Panes
YBY. Bouhnik
Y. Bouhnik
WRW. Reinisch
W. Reinisch
JSJ. Stoker
J. Stoker
STStuart A. Taylor
Stuart A. Taylor
ALAndrea Laghi
Andrea Laghi
The management of patients with IBD requires evaluation with objective tools, both at the time of diagnosis and throughout the course of the disease, to determine the location, extension, activity and severity of inflammatory lesions, as well as, the potential existence of complications. Whereas endoscopy is a well-established and uniformly performed diagnostic examination, the implementation of radiologic techniques for assessment of IBD is still heterogeneous; variations in technical aspects and the degrees of experience and preferences exist across countries in Europe. ECCO and ESGAR scientific societies jointly elaborated a consensus to establish standards for imaging in IBD using magnetic resonance imaging, computed tomography, ultrasonography, and including also other radiologic procedures such as conventional radiology or nuclear medicine examinations for different clinical situations that include general principles, upper GI tract, colon and rectum, perineum, liver and biliary tract, emergency situation, and the postoperative setting. The statements and general recommendations of this consensus are based on the highest level of evidence available, but significant gaps remain in certain areas such as the comparison of diagnostic accuracy between different techniques, the value for therapeutic monitoring, and the prognostic implications of particular findings.